We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $32.05 · 14 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Core Scientific (CORZ) officer sells 10,000 pre-planned shares - Stock Titan
Core Scientific (CORZ) officer sells 10,000 pre-planned shares Stock Titan
Director at Core Scientific (NASDAQ: CORZ) receives 18,961-share RSU equity grant - Stock Titan
Director at Core Scientific (NASDAQ: CORZ) receives 18,961-share RSU equity grant Stock Titan
Core Scientific (CORZ) director Stephen M. Smith files initial Form 3 - Stock Titan
Core Scientific (CORZ) director Stephen M. Smith files initial Form 3 Stock Titan
Core Scientific (CORZ) officer pre-planned sale, still holds 2.09M shares - Stock Titan
Core Scientific (CORZ) officer pre-planned sale, still holds 2.09M shares Stock Titan
Data center CEO Steve Smith joins Core Scientific (Nasdaq: CORZ) board - Stock Titan
Data center CEO Steve Smith joins Core Scientific (Nasdaq: CORZ) board Stock Titan
Jane Street Group (NASDAQ: CORZ) reports 23.97M shares (7.5%) disclosed - Stock Titan
Jane Street Group (NASDAQ: CORZ) reports 23.97M shares (7.5%) disclosed Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 06. | After market close (AMC) | $-0.06 | — | — | $134.34M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $1.24 | — | — | $79.53M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-4.09 | — | — | $415.75M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-3.34 | — | — | $320.39M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 28. | B. Riley Securities | — | Maintain | Buy → Buy | — | B. Riley Securities: Buy |
| 2026. 05. 15. | Jefferies | — | Maintain | Buy → Buy | — | Jefferies: Buy |
| 2026. 05. 13. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 05. 08. | Macquarie | — | Maintain | Outperform → Outperform | — | Macquarie: Outperform |
| 2026. 05. 07. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 04. 10. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.